Pharmacological properties
Pharmacodynamics. noofen also the feniletilamina is derivative gamk.
Dominating is its anti-hypoxemic and anti-amnestic action. Noofen stimulates training processes, improves memory, increases physical and mental activity. Also Noofen has tranquilizing features: eliminates psychoemotional pressure, uneasiness, fear, emotional lability, irritability, improves a dream; extends and strengthens effect of hypnotic drugs, narcotic, antipsychotic and anticonvulsants. Unlike tranquilizers, under the influence of Noofen, indicators of higher nervous activity (attention, memory, speed and accuracy of sensory-motor reactions) improve. Drug extends stage of latency and reduces duration and expressiveness of a nystagmus, has antiepileptic effect. Does not influence well-cared and adrenoceptors. Noofen considerably reduces manifestations of an asthenia and vazovegetativny symptoms, including a headache, heavy feeling in the head. At patients with an asthenia and at emotionally labile patients from the first days of therapy by medicine the health improves, interest and initiative, motivation in vigorous activity without sedation or excitement increases. It is established that at Noofen's reception at a craniocereberal injury the quantity of mitochondrions in cells of perifocal fabrics increases and biopower processes in a brain improve. In the presence of violations of action of the heart and a stomach normalizes processes of a peroksidation of lipids.
Pharmacokinetics. Drug is well soaked up after intake and well gets into all body tissues, gets through GEB. It is distributed in a liver and kidneys evenly, and in a brain and blood — unevenly. The moderate number of the entered Noofen is defined by 3 h in urine, in the same time the concentration of medicine in tissue of a brain does not decrease, it is revealed in a brain in 6 h. Next day after reception Noofen it is possible to reveal only in urine; it is defined in urine in 2 days after application, however the defined quantity is 5% of the entered dose. The greatest binding of Noofen happens in a liver (80%), it is not specific. At repeated introduction of cumulation do not note.
Indication
Decrease in intellectual and emotional activity, memory violation, decrease in concentration of attention. asthenic and alarming and neurotic states, concern, fear, alarm, neurosis of persuasive states, psychopathia. children have a stutter, enuresis, a tic. elderly people have insomnia, night concern. prevention of stressful states, before operations or painful diagnostic tests. a disease of a menyer, the dizziness connected with dysfunction of a vestibular mechanism for motion desease prevention. in complex treatment of alcoholism, for knocking over of psychopathological and somatovegetative violations at an abstinence syndrome. treatment of alcoholic predeliriozny and delirious states is combined with the standard disintoxication means. in complex treatment of women with osteochondrosis of cervicothoracic department of a backbone and climacteric disorders. prevention of stressful states before operations or painful diagnostic tests.
Use
Noofen is accepted inside to food.
Tablet on 250 mg
At asthenic and alarming and neurotic states the adult are appointed on 250–500 mg by 3 times a day. The highest single dose for adults — 750 mg, for patients of advanced age — 500 mg.
Course of treatment makes 2–3 weeks. In case of need it is possible to prolong a course of treatment up to 4–6 weeks
to Children aged from 8 years — on 250 mg 3 times in day, to children 14 years — doses for adults are aged more senior.
and at a disease Menyera Noofen tablets appointIn the dizziness connected with dysfunction of a vestibular mechanism of infectious genesis on 750 mg 3 times a day within 5–7 days, at reduction of expressiveness of vestibular frustration — on 250–500 mg 3 times a day within 5–7 days, and then — 250 mg of 1 times a day within 5 days. At rather easy course of diseases accept 250 mg 2 times a day within 5–7 days, then — 250 mg of 1 times a day within 7–10 days.
In the dizziness connected with dysfunction of a vestibular mechanism of vascular and traumatic genesis of Noofen are appointed on 250 mg by 3 times a day within 12 days.
byFor prevention of a motion desease appoint in a dose 250–500 mg once for 1 h till the expected beginning of rolling or at emergence of the first symptoms of a motion desease.
Noofen's Action amplifies at increase in a dose of medicine. In the presence of the significant manifestations (vomiting and nausea) the use of medicine is ineffective even in a dose of 750-1000 mg.
For knocking over of an alcoholic abstinence syndrome of Noofen in the first days of treatment are appointed on 250–500 mg by 3 times a day and 750 mg to night with gradual decrease in a daily dose to usual for adults.
Capsule on 250 mg
At asthenic and alarming and neurotic states the adult are appointed on 250–500 mg by 3 times a day. The highest single doses: for adults — 750 mg, to patients of advanced age — 500 mg.
Course of treatment makes 2–3 weeks. In case of need it is possible to prolong a course of treatment up to 4–6 weeks
to Children aged from 11 years — on 250 mg 3 times in day; to children 14 years — doses for adults are aged more senior.
For elimination of dizziness at dysfunction of a vestibular mechanism of infectious genesis and at a disease Menyera during Noofen's aggravation are appointed on 750 mg by 3 times a day within 5–7 days, at reduction of expressiveness of vestibular violations — on 250–500 mg 3 times a day within 5–7 days, then on 250 mg of 1 times a day within 5 days. At rather easy course of diseases of Noofen apply 250 mg of 2 times a day within 5–7 days, then — 250 mg of 1 times a day.
For elimination of dizziness at dysfunction of a vestibular mechanism of vascular and traumatic genesis of Noofen are appointed on 250 mg by 3 times a day within 12 days.
byFor prevention of a motion desease appoint in a dose 250–500 mg once for 1 h till the expected beginning of rolling at emergence of the first symptoms of a motion desease.
Noofen's Action amplifies at increase in a dose of medicine. In the presence of the significant manifestations (nausea, vomiting) the use of medicine is ineffective even in a dose of 750-1000 mg.
For knocking over of an alcoholic abstinence syndrome of Noofen in the first days of treatment are appointed on 250–500 mg by 3 times a day and 750 mg to night with gradual decrease in a daily dose to usual for adults.
Capsule on 500 mg
At asthenic and alarming and neurotic states medicament is used on 500 mg by 1–3 times a day. Maximum single doses: for adults — 750 mg, patients of advanced age — 500 mg. The course of treatment makes 2–3 weeks. In case of need the course of treatment can be increased up to 4–6 weeks
For elimination of dizziness at dysfunction of a vestibular mechanism of infectious genesis and at a disease Menyera during Noofen's aggravation apply 500 mg 4 times a day within 5–7 days, at decrease in expressiveness of vestibular frustration — on 500 mg 2–3 times a day within 5–7 days, and then on 500 mg of 1 times a day within 5 days. At rather easy course of diseases of Noofen apply 500 mg of 1 times a day within 5–7 days. Use capsules with the corresponding content of active ingredient to achievement of the recommended dose.
For elimination of dizziness at dysfunction of a vestibular mechanism of vascular and traumatic genesis of Noofen are appointed on 500 mg by 1–2 times a day within 12 days.
byFor prevention of a motion desease appoint in a dose 500 mg once for 1 h till the expected beginning of rolling or at emergence of the first symptoms of a motion desease.
Noofen's Action amplifies at increase in a dose of medicine. In the presence of the significant manifestations (nausea, vomiting) the use of medicine is ineffective even in a dose of 1000 mg.
first days of treatment of Noofen in applyFor knocking over of an alcoholic abstinence syndrome on 500 mg 3 times a day and 500 mg for the night, with gradual decrease in a daily dose to usual to adults.
If reception of one or several doses was missed by, continue reception in earlier appointed doses, if necessary or at deterioration in health the patient should consult with the doctor.
Powder for oral solution of 100 mgContents of a bag to dissolve
in ½ glasses of boiled water and to accept inside to food. The course of treatment makes 2–6 weeks
to Children at the age of 3–4 years to appoint 100 mg (1 bag) 2 times a day; 5–6 years — on 100 mg 3 times a day; 7–10 years — on 200 mg (2 bags on 100 mg) 2 times a day; 11–14 years — on 200 mg (2 bags on 100 mg) 3 times a day.
to Children 14 years are aged more senior thanit is recommended to appoint Noofen's medicine of 250 mg of a tablet or the capsule.
Highest single doses for children under 6 years — 100 mg, from 7 to 10 years — 200 mg, from 11 to 14 years — 300 mg.
For prevention of a motion desease take a single dose of medicine of 100 mg for 1 h prior to a travel sea, land or air transport.
Noofen'scan be combined with other psychotropic drugs, it increases its efficiency, at the same time it is possible to lower a dose of medicine of Noofen and other medicaments taken together with it.
Powder for oral solution of 500 mgContents of a bag to dissolve
in ½ glasses of boiled water and to accept inside to food. The course of treatment makes 2–6 weeks
Drug appoint 500 mg 1–3 times a day. If necessary the daily dose can be raised to 2.5 g (5 bags).
Noofen'scan be combined with other psychotropic drugs, it increases its efficiency, at the same time it is possible to lower a dose of medicine of Noofen and other medicaments taken together with it.
For knocking over of an alcoholic abstinence syndrome in the first days of treatment are appointed on 500 mg 2–3 times during the day also by 500 mg to night with gradual decrease in a daily dose to usual for adults.
For treatment of dizziness in case of dysfunction of the vestibular analyzer of infectious genesis (otogenic labyrinthitis) and a disease Menyera Noofen are appointed during aggravation on 500 mg by 4 times a day within 5–7 days, with reduction of expressiveness of vestibular violations — on 500 mg 2–3 times a day within 5–7 days, and then — 500 mg of 1 times a day within 5 days. At rather easy course of diseases of Noofen apply 500 mg of 1 times a day within 5–7 days, and then — on 100 mg 2–3 times a day within 7–10 days.
For treatment of dizziness in case of dysfunction of the vestibular analyzer of vascular and traumatic genesis of Noofen are appointed on 500 mg by 1–2 times a day within 12 days.
For treatment of men with erectile dysfunction of the psychogenic and mixed genesis — on 500 mg of Noofen of 1 times a day. Course of treatment of 21-28 days.
For prevention of a motion desease in the conditions of sea swimming are appointed once in a dose by 500 mg for 1 h till the expected beginning of a motion desease or at emergence of the first symptoms of seasickness.
With increase in a dose of medicine Noofen's efficiency as antinaupathic medicaments increases. In the presence of the significant manifestations of seasickness (vomiting, etc.) Noofen's application is orally ineffective even in a dose of 1000 mg.
For prevention of airsickness of Noofen are appointed once in a dose by 500 mg in 1 h before flight.
byIf one or several times did not accept in time the next dose, it is necessary to continue a course of treatment according to earlier appointed doses.
Contraindication
Hypersensitivity to drug. opn. the composition of medicine noofen in the form of powder of 500 mg, No. 30, includes aspartame, a phenylalanine source. its application contraindicated sick with phenylketonuria.
Side effects
from nervous system: drowsiness (in an initiation of treatment), a headache and dizziness (in doses it is higher than 2 g/days, at a dose decline the severity of side effects decreases).
from a GIT: nausea (in an initiation of treatment), vomiting, diarrhea, pain in epigastric area.
from a liver and biliary tract: hepatotoxicity (at prolonged use in high doses).
from the immune system: allergic reactions, including rash, an itch, urticaria, a dermahemia.
Disturbance of mentality: emotional lability, a sleep disorder (these side reactions can arise at children at use of medicine in discrepancy with the instruction for use).
Special instructions
Should be careful at appointment as the patient with pathology of a digestive tract because of irritant action of a noofen. this patient medicine is appointed in reduced doses. at prolonged use control cellular composition of blood, indicators of functional hepatic trials.
Use during pregnancy and feeding by a breast is undesirable toas there are no sufficient data confirming safety of use of medicine during this period.
Children
Tablet on 250 mg. Drug can be used at children aged from 8 years.
Capsule on 250 mg. Drug can be used at children aged from 11 years.
Capsule on 500 mg. Medicine in this dosage at children is not applied.
Powder for oral solution of 100 mg. Experience of use of medicine for children up to 3 years is not studied.
Powder for oral solution of 500 mg. Use of medicine for children is contraindicated.
Ability to influence speed of response at control of vehicles or work with other mechanisms. To patients at whom note drowsiness dizziness or other violations from central nervous system, during treatment it is impossible to steer vehicles or to work with other mechanisms.
Interaction
Noofen can be combined with psychotropic medicines, reducing doses of a noofen and the medicines applied with it.
Noofen strengthensand prolongs effect of sleeping, narcotic, antipsychotic and protivoparkinsonichesky medicines.
Overdose
Noofen malotoksichen, only in a daily dose of 7-14 g at prolonged use it can have hepatotoxic action. the specified doses considerably exceed recommended (an average therapeutic daily dose — 0.5-2.5 g). only at the highest applied dose sometimes noted an eosinophilia and fat dystrophy of a liver. at application, medicine in lower doses of such changes was not.
Symptoms: drowsiness, nausea, vomiting, development of arterial hypotension, OPN is possible.
Treatment: gastric lavage, symptomatic therapy. At complications (arterial hypotension, a renal failure) carry out additional therapy.
Storage conditions
In original packing at a temperature not above 25 °C.
Characteristics | |
Active ingredients | Phenibutum |
Amount of active ingredient | 250 mg |
Applicant | OlainFarm |
Code of automatic telephone exchange | N06BX Other psychogogic and nootropic means |
Interaction with food | To |
Light sensitivity | Not sensitive |
Market status | Original |
Prescription status | According to the prescription |
Primary packing | blister |
Producer | JOINT-STOCK COMPANY OLAYNFARM |
Quantity in packing | 20 tablets (2 blisters on 10 pieces) |
Release form | tablets for internal use |
Route of administration | Oral |
Sign | Import |
Storage temperature | from 15 °C to 25 °C |
Trade name | Noofen |
Noofen of the tab. of 250 mg No. 20
- Product Code: 179883
- In Stock
- Ready to ship
-
$71.92